Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | SRN-101 |
| Synonyms | |
| Therapy Description |
SRN-101 is an adeno-associated viral vector expressing human IFN-beta, which potentially induces immune activation and antitumor immune response (PMID: 42005833). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| SRN-101 | SRN101|SRN 101|AAV9-hIFNbeta | SRN-101 is an adeno-associated viral vector expressing human IFN-beta, which potentially induces immune activation and antitumor immune response (PMID: 42005833). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07826949 | Phase I | SRN-101 | A Phase 1 Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma. | Not yet recruiting | USA | 0 |